浏览全部资源
扫码关注微信
1.南阳市第一人民医院中医科,河南 南阳 473000
2.南阳市第一人民医院检验科,河南 南阳 473000
3.南阳市第二人民医院中医妇科,河南 南阳 473000
Received:17 October 2024,
Revised:08 February 2025,
Accepted:2025-02-19,
Published:15 March 2025
移动端阅览
王秀萍,乔献伟,徐冰.坤泰胶囊联合雌二醇片/雌二醇地屈孕酮片治疗卵巢储备功能减退的临床观察 Δ[J].中国药房,2025,36(05):589-593.
WANG Xiuping,QIAO Xianwei,XU Bing.Clinical observation of Kuntai capsule combined with Estradiol tablets/Estradiol dydrogesterone tablets in the treatment of diminished ovarian reserve[J].ZHONGGUO YAOFANG,2025,36(05):589-593.
王秀萍,乔献伟,徐冰.坤泰胶囊联合雌二醇片/雌二醇地屈孕酮片治疗卵巢储备功能减退的临床观察 Δ[J].中国药房,2025,36(05):589-593. DOI: 10.6039/j.issn.1001-0408.2025.05.15.
WANG Xiuping,QIAO Xianwei,XU Bing.Clinical observation of Kuntai capsule combined with Estradiol tablets/Estradiol dydrogesterone tablets in the treatment of diminished ovarian reserve[J].ZHONGGUO YAOFANG,2025,36(05):589-593. DOI: 10.6039/j.issn.1001-0408.2025.05.15.
目的
2
观察坤泰胶囊联合雌二醇片/雌二醇地屈孕酮片治疗卵巢储备功能减退(DOR)的临床疗效、安全性、复发情况及对患者卵巢储备功能、性激素和淋巴细胞亚群的影响。
方法
2
回顾性分析南阳市第一人民医院165例DOR患者的临床资料,将其中80例采用雌二醇片/雌二醇地屈孕酮片(按说明书用药顺序每天1片)者纳入对照组,85例在对照组基础上联用坤泰胶囊(每次2.0 g,每天3次)者纳入观察组,两组疗程均为3个月。比较两组患者的临床疗效、不良反应发生率、复发率以及治疗前后的中医证候积分、卵巢储备功能指标[抗米勒管激素(AMH)、抑制素B(INHB)、窦卵泡计数(AFC)、子宫内膜厚度及卵巢体积
]
、性激素[促卵泡激素(FSH)、黄体生成素(LH)和雌二醇(E
2
)
]
和T淋巴细胞亚群指标(CD3
+
、CD4
+
、CD8
+
、CD4
+
/CD8
+
)情况。
结果
2
观察组患者的愈显率显著高于对照组(82.35% vs
.
65.00%,
P
<0.05)。与治疗前比较,两组患者治疗后的中医证候积分、FSH和LH水平、CD3
+
、CD8
+
均显著降低,AMH、INHB、E
2
水平和CD4
+
、CD4
+
/CD8
+
、AFC、子宫内膜厚度、卵巢体积均显著升高或增加(
P
<0.05),且观察组上述指标的改善程度均显著优于对照组(
P
<0.05)。两组患者的不良反应总发生率无明显差异(
P
>0.05)。观察组患者治疗后6个
月内的复发率显著低于对照组(5.88% vs
.
21.25%,
P
<0.05)。
结论
2
坤泰胶囊联合雌二醇片/雌二醇地屈孕酮片治疗DOR的疗效显著,可改善患者卵巢储备功能,调节其性激素和T淋巴细胞亚群水平,减少复发,且安全性较高。
OBJECTIVE
2
To observe the clinical efficacy, safety and recurrence of Kuntai capsules combined with Estradiol tablets/Estradiol dydrogesterone tablets in the treatment of diminished ovarian reserve (DOR) as well as their effects on ovarian reserve function, sex hormones, and lymphocyte subsets.
METHODS
2
A retrospective analysis was conducted on the clinical data of 165 DOR patients in Nanyang First People’s Hospital. Among them, 80 patients who received Estradiol tablets/Estradiol dydrogesterone tablets (take one tablet per day according to the medication sequence on the instruction) were included in the control group, while 85 patients who additionally took Kuntai capsules (2.0 g per dose, three times daily) were included in the observation group. The treatment duration for both groups was three months. Clinical efficacy, the incidence of adverse drug reaction (ADR), recurrence rate, and changes in Traditional Chinese Medicine (TCM) syndrome scores, ovarian reserve function indicators [anti-Müllerian hormone (AMH), inhibin B (INHB), antral follicle count (AFC), endometrial thickness, and ovarian volume
]
, sex hormones [follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E
2
)
]
, and T lymphocyte subsets (CD3
+
, CD4
+
, CD8
+
, and CD4
+
/CD8
+
) were compared before and after treatment.
RESULTS
2
The cure and significant improvement rate in the observation group was significantly higher than in the control group (82.35% vs. 65.00%,
P
<0.05). Compared to baseline levels, both groups showed significant reductions in TCM syndrome scores, FSH, LH, CD3
+
and CD8
+
level
s after treatment, while AMH, INHB, E
2
, CD4
+
, CD4
+
/CD8
+
, AFC, endometrial thickness, and ovarian volume significantly increased (
P
<0.05). The degree of improvement in these indicators was significantly greater in the observation group than in the control group (
P
<0.05). There was no significant difference in the total incidence of ADR between the two groups(
P
>0.05). However, the recurrence rate within six months post-treatment was significantly lower in the observation group compared to the control group (5.88% vs.
21.25%,
P
<0.05).
CONCLUSIONS
2
Kuntai capsules combined with Estradiol tablets/Estradiol dydrogesterone tablets have a significant therapeutic effect on DOR, which can improve ovarian reserve function of the patient, regulate sex hormone levels and T lymphocyte subsets, and reduce recurrence rates, with a high safety profile.
郑娟 , 周黎明 , 孙亦婷 , 等 . 高龄合并卵巢储备功能低下患者三种促排卵方案的临床结局比较 [J ] . 中华生殖与避孕杂志 , 2020 , 40 ( 3 ): 194 - 200 .
ZHENG J , ZHOU L M , SUN Y T , et al . Comparison of the clinical outcomes of three ovulation induction protocols in elderly patients with decline in ovarian reserve [J ] . Chin J Reprod Contracept , 2020 , 40 ( 3 ): 194 - 200 .
ZHANG Q L , LEI Y L , DENG Y , et al . Treatment pro- gress in diminished ovarian reserve:western and Chinese medicine [J ] . Chin J Integr Med , 2023 , 29 ( 4 ): 361 - 367 .
徐晶 , 李莹 . 疏肝补肾活血方联合激素替代治疗卵巢早衰的效果及其对卵巢储备功能和骨代谢的改善作用研究 [J ] . 中国性科学 , 2022 , 31 ( 10 ): 122 - 125 .
XU J , LI Y . Study of curative effect of Shugan bushen huoxue decoction combined with hormone replacement therapy in patients with premature ovarian failure and its improvement effect on ovarian reserve function and bone metabolism [J ] . Chin J Hum Sex , 2022 , 31 ( 10 ): 122 - 125 .
王凤玲 , 严雪征 . 坤泰胶囊联合替勃龙对更年期综合征妇女内分泌及免疫功能的影响 [J ] . 宁夏医科大学学报 , 2018 , 40 ( 5 ): 569 - 572 .
WANG F L , YAN X Z . The effect of Kuntai capsule combined with tibolon on endocrine and immune function in women with menopausal syndrome [J ] . J Ningxia Med Univ , 2018 , 40 ( 5 ): 569 - 572 .
辛喜艳 , 叶阳 , 樊瑞文 , 等 . 不孕症(卵巢储备功能减退)的中西医结合诊疗方案 [J ] . 北京中医药 , 2024 , 43 ( 2 ): 119 - 123 .
XIN X Y , YE Y , FAN R W , et al . Diagnosis and treatment plan of integrated Chinese and Western medicine for infertility(decreased ovarian reserve function) [J ] . Beijing J Tradit Chin Med , 2024 , 43 ( 2 ): 119 - 123 .
卵巢储备功能减退临床诊治专家共识专家组 , 中华预防医学会生育力保护分会生殖内分泌生育保护学组 . 卵巢储备功能减退临床诊治专家共识 [J ] . 生殖医学杂志 , 2022 , 31 ( 4 ): 425 - 434 .
Expert Group of Consensus on Clinical Diagnosis & Ma- nagement of Diminished Ovarian Reserve , Reproductive Endocrinology & Fertility Preservation Section of Chinese Society on Fertility Preservation under Chinese Preventive Medicine Association . Consensus on clinical diagnosis and management of diminished ovarian reserve [J ] . J Reprod Med , 2022 , 31 ( 4 ): 425 - 434 .
国家中医药管理局 . 中医妇科病证诊断疗效标准 [S/ OL ] .[ 2024-08-18 ] . https://www.renrendoc.com/paper/2179- 10971.html https://www.renrendoc.com/paper/2179-10971.html .
State Administration of Traditional Chinese Medicine . Diagnostic and therapeutic criteria for traditional Chinese medicine gynecological diseases and syndromes [S/OL ] .[ 2024-08-18 ] . https://www.renrendoc.com/paper/217910- 971.html https://www.renrendoc.com/paper/217910-971.html .
李晓林 , 汤华 , 李丽 . 归肾丸加减联合芬吗通治疗卵巢储备功能低下性不孕患者临床效果及对性激素水平影响 [J ] . 临床误诊误治 , 2019 , 32 ( 5 ): 54 - 58 .
LI X L , TANG H , LI L . Clinical effect of Guishen pills combined with Femoston in treating patients with inferti- lity due to diminished ovarian reserve and their effect on sex hormone level [J ] . Clin Misdiagnosis Mistherapy , 2019 , 32 ( 5 ): 54 - 58 .
郑筱萸 . 中药新药临床研究指导原则:试行 [M ] . 北京 : 中国医药科技出版社 , 2002 : 385 - 388 .
ZHENG X Y . Guiding principles for clinical research of traditional Chinese medicine new drugs:trial [M ] . Beijing : China Medical Science and Technology Press , 2002 : 385 - 388 .
吴琼 , 李焱 . 归肾育宫汤联合雌孕激素序贯治疗卵巢早衰疗效及对血清性激素的影响 [J ] . 四川中医 , 2022 , 40 ( 4 ): 163 - 165 .
WU Q , LI Y . Effect of Guishen yugong decoction combined with estrogen and progesterone on premature ova- rian failure and its influence on serum sex hormones [J ] . J Sichuan Tradit Chin Med , 2022 , 40 ( 4 ): 163 - 165 .
张泓源 , 王丽 , 刘静君 . 基于“阳化气,阴成形”探讨女性卵巢储备功能低下 [J ] . 中医药信息 , 2022 , 39 ( 5 ): 23 - 26 .
ZHANG H Y , WANG L , LIU J J . Discussion on DOR based on‘Yang transforming into Qi,Yin constituting form’ [J ] . Inf Tradit Chin Med , 2022 , 39 ( 5 ): 23 - 26 .
ZHANG X D , ZHANG L N , XIONG L , et al . Kuntai capsule for the treatment of diminished ovarian reserve:a systematic review and meta-analysis of randomized controlled trials [J ] . J Ethnopharmacol , 2024 , 329 : 118167 .
张璇 , 刘佳欣 , 夏晨 , 等 . 基于GnRH及其受体介导下丘脑-垂体-卵巢轴探讨温和灸干预妇科寒凝血瘀证作用机制 [J ] . 中国中医药信息杂志 , 2025 , 32 ( 2 ): 113 - 119 .
ZHANG X , LIU J X , XIA C , et al . Exploration on the mechanism of mild moxibustion intervention on gynecological cold coagulation and blood stasis syndrome based on GnRH and its receptor mediated HPO axis [J ] . Chin J Inf Tradit Chin Med , 2025 , 32 ( 2 ): 113 - 119 .
马琰 , 李浩 , 杨书阁 . 雌孕激素序贯联合坤泰胶囊治疗早发性卵巢功能不全的效果观察 [J ] . 中华全科医师杂志 , 2023 , 22 ( 3 ): 301 - 303 .
MA Y , LI H , YANG S G . Efficacy of Chinese medicine Kuntai capsule combined with sequential estrogen progesterone therapy in treatment of early-onset ovarian dysfunction [J ] . Chin J Gen Pract , 2023 , 22 ( 3 ): 301 - 303 .
蒋玲玲 , 汤卫春 , 康心怡 , 等 . 坤泰胶囊联合雌孕激素替代疗法对卵巢早衰的疗效及对Treg、Th17、VEGF的影响 [J ] . 中药材 , 2023 , 46 ( 9 ): 2336 - 2340 .
JIANG L L , TANG W C , KANG X Y , et al . Effect of Kuntai capsule combined with estrogen and progesterone replacement therapy on premature ovarian failure and its influence on Treg,Th17 and VEGF [J ] . J Chin Med Mater , 2023 , 46 ( 9 ): 2336 - 2340 .
丁淼 , 王良岸 , 李扬志 , 等 . 坤泰胶囊改善GnRH-a所致围绝经期症状的前瞻性随机对照研究 [J ] . 中国实用妇科与产科杂志 , 2019 , 35 ( 4 ): 462 - 465 .
DING M , WANG L A , LI Y Z , et al . Effects of Kuntai capsule on GnRH-a-induced perimenopause symptoms:a prospective randomized controlled study [J ] . Chin J Pract Gynecol Obstet , 2019 , 35 ( 4 ): 462 - 465 .
饶阳阳 , 朱霞玲 , 陈珉 . 卵巢储备功能低下患者血清淋巴细胞亚群表达与卵巢储备功能指标的交互作用 [J ] . 中国计划生育学杂志 , 2023 , 31 ( 9 ): 2208 - 2213 .
RAO Y Y , ZHU X L , CHEN M . Interaction between the expressions of serum lymphocyte subsets of patients with low ovarian reserve and their ovarian reserve function indicator [J ] . Chin J Fam Plan , 2023 , 31 ( 9 ): 2208 - 2213 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution